Andrew Namkung
Andrew Namkung is an attorney in Holland & Knight’s Boston office and a member of the firm’s Healthcare Regulatory & Enforcement Practice Group. His practice comprises three broad categories, all within the healthcare and life sciences industry: regulatory advising, investigations and enforcement actions, and healthcare transactions.
Mr. Namkung’s regulatory practice involves advising clients on a wide range of healthcare issues, including fraud, abuse, compliance, pricing, reimbursement and licensing matters. He has experience counseling a wide range of clients in the healthcare industry, including manufacturers, pharmacy benefit managers, pharmacy chains, managed care organizations and healthcare information technology companies. Mr. Namkung frequently advises clients on complex business relationships and joint ventures within the healthcare industry, in particular, to comply with healthcare fraud and abuse laws. He also has experience assisting life sciences companies navigate the Controlled Substances Act and state law analogues. Moreover, he has experience navigating the Food, Drug, and Cosmetic Act (FD&C Act) and the Health Insurance Portability and Accountability Act (HIPAA).
In the enforcement context, Mr. Namkung has experience representing clients in healthcare white-collar criminal proceedings and in civil healthcare cases, with an emphasis on healthcare fraud and abuse matters such as those involving the Anti-Kickback Statute (AKS), False Claims Act (FCA), Stark Law and the healthcare fraud statute. Mr. Namkung has also conducted numerous internal investigations and assisted clients with responding to inquiries by the Office of Inspector General (OIG) and subpoenas issued by the U.S. Department of Justice (DOJ) and U.S. Attorney’s Offices.
On the transactions side, Mr. Namkung has performed targeted healthcare regulatory diligence and licensure analysis in connection with healthcare mergers, acquisitions, sales and investments, including for non-healthcare clients such as private equity firms, lenders and underwriters.